TG Therapeutics TGTX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's total assets?
- TG Therapeutics (TGTX) reported total assets of $1.53B in Q1 2026.
- How has TG Therapeutics's total assets changed year-over-year?
- TG Therapeutics's total assets increased by 132.8% year-over-year, from $656.69M to $1.53B.
- What is the long-term trend for TG Therapeutics's total assets?
- Over 5 years (2020 to 2025), TG Therapeutics's total assets has grown at a 11.2% compound annual growth rate (CAGR), from $625.64M to $1.06B.
- What does total assets mean?
- The total value of everything the company owns.
- How do you interpret total assets?
- Growth in total assets generally signals business expansion, though it must be balanced against the liabilities used to fund those assets.
- How does total assets compare across companies?
- Total assets vary significantly based on the company's business model, with asset-light biotech firms typically having lower totals than manufacturing-heavy peers.